|
Be one of the 50 investors selected to Beta Test our online trading site and be eligible to purchase shares of future IPOs we participate in!**
As a potential investor in the Life Sciences, you should be well aware of the rapid developments taking place in both the pharmaceutical and biotech industries. In fact, the entire product pipeline is teeming with over
2,000 drugs under development and an additional 300 in Phase III or awaiting FDA approval.
How do you make the most of your knowledge to make informed investment choices? How can you capitalize on the tremendous financial opportunities that are available right now? The answer is eMedsecurities. We
are an electronic investment bank and online trading site that facilitates a knowledge-based approach toward investing in the Life Sciences Market.
Help Test Our Revolutionary New Investment Web Site and Discover a Wealth of Opportunities in the Small Cap Life Sciences Market!
To see if you qualify to test the launch of our new online trading site (Beta version) and to get in on this exciting opportunity, please click
here:** As a participating Beta Tester, you will receive:
-
Eligibility to purchase shares in IPOs that eMedsecurities participates in for as long as you maintain your account**
-
Valuable research of the entire Product Pipeline of companies, including stages of clinical development, by industry or
specific disease
-
Useful information about industry trends, recent developments and upcoming IPOs
-
Commitment to customer service featuring our Live Customer Service Online
-
Dedication to fast trade executions at the best possible price
Our knowledge-based approach incorporates the following:
- Comprehensive Disease Hub Database- Our Disease Hub Database effectively consolidates scientific and financial information into one easy-to-understand abstract. It is
an invaluable resource for investing in the Life Sciences Market.
- Advisory Boards- To help keep us aware of trends, our members include Nobel Laureates in physiology and medicine, pioneers in drug discovery, as well as recognized
top strategic planners in the worldwide Pharmaceutical Industry.
- Webcasts- Participate in regular webcasts and live chat sessions with leaders in the Pharmaceutical and Biotechnology spaces.
- Free eMedUpdates - Get periodic updates delivered directly to your email on upcoming IPOs we participate in, webcasts and
new features. [Sign Up]
Now you can take advantage of the wealth of information we have compiled to make more informed investment decisions in the Life Sciences. eMedsecurities enables you to learn about new research and upcoming treatments for diseases like arthritis, breast and
colon cancer, Parkinson�s disease and more. Then examine the financial information about the companies that are developing them, all from a single source.
Buy and sell any publicly traded company with eMedsecurities!
Click here: to see if you qualify to become a Beta Tester of our new Web site. Your participation and feedback will be greatly appreciated while assuring you eligibility to purchase
shares of future IPOs in which we take part!
Please note: All applications for the Beta Test must be in by 1/12/01 to be considered.
Research indicated that you might benefit from our offer. To discontinue receipt of further notice and to be removed from our database, simply click here: [EMAIL PROTECTED]?subject=remove, or go to
our Opt Out page, to be instantly and permanently removed. We respect all removal requests.
** Restrictions Apply: Beta test open only to those residents of: AK, AR, CA, CT, DC, DE, FL, GA, ID, IN, IA, KY, LA, MA, MD, ND, NV, NY, OH, PA, SC, SD, VA, WA, WV, WI, WY. Initial Public Offerings are considered speculative investments and as such may not be appropriate for every investor.
If an investor chooses to participate in IPOs, there are certain restrictions that apply:Flipping - The first time an investor sells his/her shares within the first 30 days the issue is trading in the secondary market, that investor will not be allocated shares for the
next 90 days following the sale. The second time that investor �flips�; they will not be allocated IPO shares for 180 days. The third time that investor �flips�; they lose their IPO allocations permanently. Transferring shares - If the investor
transfers IPO shares out of their account within the first 30 days the issue is trading in the secondary market, they will permanently lose their IPO allocations. Beta investors will be chosen from all of the applicants based on their income, net worth and investing experience. IPO shares
will only be allocated from transactions in which eMedsecurities is participating in the underwriting. 010301-0100-A0003-1-A3
|
